Source: ktsimage/Getty Images

Innovator: If ‘Overall’ Underwhelms, Turn to RNA-Seq

RNA-seq is helping researchers take a fresh look at gene expression and its relationship to biological phenomena.
frank peters/Fotolia

Illumina to Acquire GenoLogics Life Sciences Software

Illumina said today it will acquire GenoLogics Life Sciences Software, a developer of laboratory information management systems (LIMS) for life science organizations, in a...
Source: iStock/Evgeny Terentev

Tumor-Only Sequences Riddled with Mutational False-Positives

Many of the mutations that are found with tumor-only genetic sequencing are not actually tumor-related. Instead, they are just germline mutations, which are inherited...
DNAnexus is making available on its cloud-based platform the DeepVariant bioinformatics tool

Google-Developed DeepVariant Included on DNAnexus Platform

DNAnexus taps the open-source variant calling tool on its cloud-based platform through a pilot program to serve its broad range of customers
Source: dem10/ Getty Images

Researchers ID Disease-Causing Mutations in the Exome That Alter Gene Splicing

To help identify disease-causing variants in the genome, researchers developed a tool that works by producing artificial “minigenes.”
Doctor Offering Drug Personalized By Genome Test

NIH to Evaluate Use of Genomics to Inform Chronic Disease Treatment

The NIH plans to spend $42 million over five years to fund clinical trials designed to evaluate whether and how the management of diseases...
The Broad Institute of MIT and Harvard and the Dana-Farber Cancer Institute have launched the Metastatic Prostate Cancer (MPC) Project

The Broad, Dana-Farber Launch Metastatic Prostate Cancer Project

Initiative designed to encourage men with the disease in the U.S. and Canada to share their data with researchers studying the disease
Boy with Surgical Mask

Asymptomatic People Infected with SARS-CoV-2 May Have Weaker Immune Response to Virus

The researchers from Chongqing Medical University in Chongqing, China, also found that people’s antibody response to SARS-CoV-2 may diminish rapidly after infection, which may have implications for the interpretation of negative serological results.
male scientist pipettes in lab

CRISPR Comes of Age—As a Diagnostic

Hailed for its gene editing power, Sherlock Bioscience’s COVID-19 diagnostic is the first CRISPR technology to gain FDA approval.Hailed for its gene editing power, Sherlock Bioscience’s COVID-19 diagnostic is the first CRISPR technology to gain FDA approval.
Source: Getty Images

Agios Gains FDA Approval for Precision AML Drug

Tibsovo gains approval for adult patients with relapsed or refractory acute myeloid leukemia with specific mutations in the IDH1 gene
Scroll Up